Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Melanoma | 12 | 2023 | 5691 | 0.750 |
Why?
|
Pets | 1 | 2019 | 47 | 0.630 |
Why?
|
Myocarditis | 5 | 2021 | 766 | 0.510 |
Why?
|
Dogs | 1 | 2019 | 3840 | 0.450 |
Why?
|
Physicians, Women | 1 | 2019 | 495 | 0.420 |
Why?
|
MAP Kinase Signaling System | 1 | 2019 | 1477 | 0.400 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2023 | 2053 | 0.350 |
Why?
|
Nervous System Diseases | 1 | 2019 | 1647 | 0.320 |
Why?
|
Medical Oncology | 2 | 2019 | 2312 | 0.300 |
Why?
|
Skin Neoplasms | 4 | 2022 | 5797 | 0.270 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3242 | 0.250 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5629 | 0.220 |
Why?
|
Brain Neoplasms | 4 | 2024 | 8981 | 0.180 |
Why?
|
Histoplasma | 1 | 2020 | 39 | 0.180 |
Why?
|
Physicians | 1 | 2018 | 4580 | 0.180 |
Why?
|
Histoplasmosis | 1 | 2020 | 63 | 0.170 |
Why?
|
Prognosis | 2 | 2024 | 29557 | 0.170 |
Why?
|
Neoplasms | 5 | 2021 | 22032 | 0.170 |
Why?
|
Meningeal Carcinomatosis | 1 | 2020 | 63 | 0.170 |
Why?
|
Lung Diseases, Fungal | 1 | 2020 | 126 | 0.170 |
Why?
|
Genes, cdc | 1 | 2019 | 115 | 0.160 |
Why?
|
Polymyalgia Rheumatica | 1 | 2018 | 53 | 0.160 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2021 | 345 | 0.150 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2020 | 167 | 0.150 |
Why?
|
Molecular Targeted Therapy | 2 | 2019 | 2796 | 0.140 |
Why?
|
Gastritis | 1 | 2019 | 199 | 0.140 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2024 | 5249 | 0.140 |
Why?
|
Immunotherapy | 4 | 2019 | 4641 | 0.130 |
Why?
|
Gastric Mucosa | 1 | 2019 | 600 | 0.130 |
Why?
|
Uveal Neoplasms | 1 | 2019 | 341 | 0.130 |
Why?
|
Arthritis, Psoriatic | 1 | 2018 | 219 | 0.130 |
Why?
|
Mutation | 2 | 2023 | 29915 | 0.130 |
Why?
|
Heart Conduction System | 1 | 2021 | 1011 | 0.130 |
Why?
|
Glucocorticoids | 2 | 2021 | 2144 | 0.120 |
Why?
|
Adrenal Cortex Hormones | 2 | 2020 | 1870 | 0.120 |
Why?
|
Hepatitis B, Chronic | 1 | 2018 | 403 | 0.120 |
Why?
|
Antibodies, Monoclonal | 3 | 2019 | 9160 | 0.110 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2019 | 708 | 0.110 |
Why?
|
Action Potentials | 1 | 2021 | 1816 | 0.110 |
Why?
|
Radiation Oncology | 1 | 2019 | 563 | 0.110 |
Why?
|
Neurosurgery | 1 | 2019 | 670 | 0.110 |
Why?
|
Registries | 4 | 2021 | 8175 | 0.090 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 1185 | 0.090 |
Why?
|
Skin Diseases | 1 | 2019 | 1088 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2020 | 5246 | 0.090 |
Why?
|
Hepatitis C, Chronic | 1 | 2018 | 1031 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2018 | 1585 | 0.080 |
Why?
|
Heart Rate | 1 | 2021 | 4166 | 0.080 |
Why?
|
Lung Neoplasms | 4 | 2020 | 13245 | 0.080 |
Why?
|
Stomach Neoplasms | 1 | 2019 | 1422 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2500 | 0.080 |
Why?
|
Humans | 28 | 2024 | 758406 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 4342 | 0.080 |
Why?
|
Antineoplastic Agents | 3 | 2020 | 13591 | 0.070 |
Why?
|
Sarcoma | 1 | 2019 | 1785 | 0.070 |
Why?
|
Electrocardiography | 1 | 2021 | 6363 | 0.070 |
Why?
|
Echocardiography | 1 | 2020 | 4962 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2019 | 3586 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3609 | 0.070 |
Why?
|
Female | 17 | 2024 | 390323 | 0.060 |
Why?
|
Male | 14 | 2024 | 358747 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2022 | 80168 | 0.060 |
Why?
|
Pain | 1 | 2019 | 5065 | 0.060 |
Why?
|
Palliative Care | 1 | 2019 | 3570 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2023 | 6852 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4876 | 0.050 |
Why?
|
Arthritis, Rheumatoid | 1 | 2018 | 3755 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7985 | 0.050 |
Why?
|
Aged | 12 | 2024 | 168218 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2017 | 3217 | 0.050 |
Why?
|
Oximes | 1 | 2023 | 303 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16534 | 0.050 |
Why?
|
Middle Aged | 12 | 2024 | 219568 | 0.050 |
Why?
|
Pyrimidinones | 1 | 2023 | 383 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 640 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2021 | 58683 | 0.040 |
Why?
|
Inpatients | 2 | 2021 | 2551 | 0.040 |
Why?
|
Polyneuropathies | 1 | 2019 | 137 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10748 | 0.040 |
Why?
|
Pyridones | 1 | 2023 | 784 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 555 | 0.040 |
Why?
|
Nausea | 1 | 2020 | 677 | 0.040 |
Why?
|
Quality of Life | 1 | 2019 | 13285 | 0.040 |
Why?
|
Vomiting | 1 | 2020 | 651 | 0.030 |
Why?
|
Animals | 2 | 2019 | 167768 | 0.030 |
Why?
|
Methylprednisolone | 1 | 2018 | 384 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 64378 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2017 | 551 | 0.030 |
Why?
|
Gadolinium | 1 | 2020 | 959 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15225 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2024 | 2638 | 0.030 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2020 | 1044 | 0.030 |
Why?
|
Troponin T | 1 | 2018 | 761 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21017 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11709 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4839 | 0.030 |
Why?
|
HIV Infections | 1 | 2018 | 17275 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2020 | 1368 | 0.020 |
Why?
|
Piperazines | 1 | 2021 | 2511 | 0.020 |
Why?
|
Hospitalization | 2 | 2021 | 10652 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2020 | 3759 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2020 | 6821 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4901 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3816 | 0.020 |
Why?
|
Time Factors | 2 | 2021 | 39872 | 0.020 |
Why?
|
Dermatology | 1 | 2019 | 914 | 0.020 |
Why?
|
Pyridines | 1 | 2021 | 2859 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6768 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8823 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8530 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3858 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12721 | 0.020 |
Why?
|
Contrast Media | 1 | 2020 | 5298 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2021 | 11152 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4158 | 0.020 |
Why?
|
Stroke Volume | 1 | 2020 | 5460 | 0.020 |
Why?
|
Adult | 4 | 2024 | 219935 | 0.020 |
Why?
|
Graft Rejection | 1 | 2018 | 4426 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2024 | 39059 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7378 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9273 | 0.010 |
Why?
|
Lung | 1 | 2020 | 9985 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 8506 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22029 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 23884 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41256 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20500 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36284 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2018 | 15637 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15399 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 54137 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 73809 | 0.010 |
Why?
|
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(79)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_